These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

730 related items for PubMed ID: 12714745

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. Fibrillization of alpha-synuclein and tau in familial Parkinson's disease caused by the A53T alpha-synuclein mutation.
    Kotzbauer PT, Giasson BI, Kravitz AV, Golbe LI, Mark MH, Trojanowski JQ, Lee VM.
    Exp Neurol; 2004 Jun; 187(2):279-88. PubMed ID: 15144854
    [Abstract] [Full Text] [Related]

  • 3. From genetics to pathology: tau and alpha-synuclein assemblies in neurodegenerative diseases.
    Goedert M, Spillantini MG, Serpell LC, Berriman J, Smith MJ, Jakes R, Crowther RA.
    Philos Trans R Soc Lond B Biol Sci; 2001 Feb 28; 356(1406):213-27. PubMed ID: 11260802
    [Abstract] [Full Text] [Related]

  • 4. Following the leader: fibrillization of alpha-synuclein and tau.
    Frasier M, Wolozin B.
    Exp Neurol; 2004 Jun 28; 187(2):235-9. PubMed ID: 15144849
    [No Abstract] [Full Text] [Related]

  • 5. Interaction of the molecular chaperone alphaB-crystallin with alpha-synuclein: effects on amyloid fibril formation and chaperone activity.
    Rekas A, Adda CG, Andrew Aquilina J, Barnham KJ, Sunde M, Galatis D, Williamson NA, Masters CL, Anders RF, Robinson CV, Cappai R, Carver JA.
    J Mol Biol; 2004 Jul 23; 340(5):1167-83. PubMed ID: 15236975
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Tau and 14-3-3 in glial cytoplasmic inclusions of multiple system atrophy.
    Giasson BI, Mabon ME, Duda JE, Montine TJ, Robertson D, Hurtig HI, Lee VM, Trojanowski JQ.
    Acta Neuropathol; 2003 Sep 23; 106(3):243-50. PubMed ID: 12811584
    [Abstract] [Full Text] [Related]

  • 8. PA700, the regulatory complex of the 26S proteasome, interferes with alpha-synuclein assembly.
    Ghee M, Melki R, Michot N, Mallet J.
    FEBS J; 2005 Aug 23; 272(16):4023-33. PubMed ID: 16098186
    [Abstract] [Full Text] [Related]

  • 9. Cleavage of alpha-synuclein by calpain: potential role in degradation of fibrillized and nitrated species of alpha-synuclein.
    Mishizen-Eberz AJ, Norris EH, Giasson BI, Hodara R, Ischiropoulos H, Lee VM, Trojanowski JQ, Lynch DR.
    Biochemistry; 2005 May 31; 44(21):7818-29. PubMed ID: 15909996
    [Abstract] [Full Text] [Related]

  • 10. Lewy bodies in the amygdala: increase of alpha-synuclein aggregates in neurodegenerative diseases with tau-based inclusions.
    Popescu A, Lippa CF, Lee VM, Trojanowski JQ.
    Arch Neurol; 2004 Dec 31; 61(12):1915-9. PubMed ID: 15596612
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Effects of alpha-tocopherol on an animal model of tauopathies.
    Nakashima H, Ishihara T, Yokota O, Terada S, Trojanowski JQ, Lee VM, Kuroda S.
    Free Radic Biol Med; 2004 Jul 15; 37(2):176-86. PubMed ID: 15203189
    [Abstract] [Full Text] [Related]

  • 13. More than just two peas in a pod: common amyloidogenic properties of tau and alpha-synuclein in neurodegenerative diseases.
    Lee VM, Giasson BI, Trojanowski JQ.
    Trends Neurosci; 2004 Mar 15; 27(3):129-34. PubMed ID: 15036877
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Tau phosphorylation increases in symptomatic mice overexpressing A30P alpha-synuclein.
    Frasier M, Walzer M, McCarthy L, Magnuson D, Lee JM, Haas C, Kahle P, Wolozin B.
    Exp Neurol; 2005 Apr 15; 192(2):274-87. PubMed ID: 15755545
    [Abstract] [Full Text] [Related]

  • 17. Antiapoptotic property of human alpha-synuclein in neuronal cell lines is associated with the inhibition of caspase-3 but not caspase-9 activity.
    Li W, Lee MK.
    J Neurochem; 2005 Jun 15; 93(6):1542-50. PubMed ID: 15935070
    [Abstract] [Full Text] [Related]

  • 18. Inhibition of alpha-synuclein fibrillization by dopamine analogs via reaction with the amino groups of alpha-synuclein. Implication for dopaminergic neurodegeneration.
    Li HT, Lin DH, Luo XY, Zhang F, Ji LN, Du HN, Song GQ, Hu J, Zhou JW, Hu HY.
    FEBS J; 2005 Jul 15; 272(14):3661-72. PubMed ID: 16008565
    [Abstract] [Full Text] [Related]

  • 19. Alpha-synuclein and transgenic mouse models.
    Fernagut PO, Chesselet MF.
    Neurobiol Dis; 2004 Nov 15; 17(2):123-30. PubMed ID: 15474350
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 37.